MLTX logo

MLTX Shareholders equity

annual shareholders equity:

$446.82M-$48.85M(-9.86%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLTX annual stockholders equity is $446.82 million, with the most recent change of -$48.85 million (-9.86%) on December 31, 2024.
  • During the last 3 years, MLTX annual shareholders equity has risen by +$458.47 million (+3937.05%).
  • MLTX annual shareholders equity is now -9.86% below its all-time high of $495.68 million, reached on December 31, 2023.

Performance

MLTX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

quarterly shareholders equity:

$407.52M-$39.30M(-8.80%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLTX quarterly stockholders equity is $407.52 million, with the most recent change of -$39.30 million (-8.80%) on March 31, 2025.
  • Over the past year, MLTX quarterly shareholders equity has dropped by -$135.03 million (-24.89%).
  • MLTX quarterly shareholders equity is now -24.89% below its all-time high of $542.55 million, reached on March 31, 2024.

Performance

MLTX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MLTX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.9%-24.9%
3 y3 years+3937.1%-
5 y5 years+3937.1%-

MLTX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-9.9%+3937.1%-24.9%+870.3%
5 y5-year-9.9%+3937.1%-24.9%+3599.5%
alltimeall time-9.9%+3937.1%-24.9%+3599.5%

MLTX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$407.52M(-8.8%)
Dec 2024
$446.82M(-9.9%)
$446.82M(-8.5%)
Sep 2024
-
$488.20M(-6.2%)
Jun 2024
-
$520.66M(-4.0%)
Mar 2024
-
$542.55M(+9.5%)
Dec 2023
$495.68M
$495.68M(+16.6%)
DateAnnualQuarterly
Sep 2023
-
$424.93M(-13.2%)
Jun 2023
-
$489.80M(+1066.2%)
Mar 2023
-
$42.00M(-14.1%)
Dec 2022
$48.90M(-519.9%)
$48.90M(-11.6%)
Sep 2022
-
$55.29M(-13.0%)
Jun 2022
-
$63.51M(-645.4%)
Dec 2021
-$11.64M
-$11.64M

FAQ

  • What is MoonLake Immunotherapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?

What is MoonLake Immunotherapeutics annual stockholders equity?

The current annual shareholders equity of MLTX is $446.82M

What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual stockholders equity is $495.68M

What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?

Over the past year, MLTX annual stockholders equity has changed by -$48.85M (-9.86%)

What is MoonLake Immunotherapeutics quarterly stockholders equity?

The current quarterly shareholders equity of MLTX is $407.52M

What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly stockholders equity is $542.55M

What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?

Over the past year, MLTX quarterly stockholders equity has changed by -$135.03M (-24.89%)
On this page